Early Human Development
Volume 86, Issue 5 , Pages 295-298 , May 2010

BNP concentrations and cardiovascular adaptation in preterm and fullterm newborn infants

  • Savina Mannarino

      Affiliations

    • Pediatric Cardiology, Department of Paediatrics, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy
    • ,
  • Francesca Garofoli

      Affiliations

    • Neonatal Immunology Laboratory, Neonatal Intensive Care Unit Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy
    • Corresponding Author InformationCorresponding author. Neonatal Immunology Research Laboratories, Neonatology and Neonatal Intensive Care Unit Fondazione IRCCS Policlinico San Matteo, Pavia, Italy Piazzale Golgi 1, 27100 Pavia, Italy. Tel.: +39 0382 502865; fax: +39 0382 502802.
    • ,
  • Elisa Mongini

      Affiliations

    • Neonatology and Neonatal Intensive Care Unit, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy
    • ,
  • Rosa Maria Cerbo

      Affiliations

    • Neonatology and Neonatal Intensive Care Unit, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy
    • ,
  • Alessia Claudia Codazzi

      Affiliations

    • Pediatric Cardiology, Department of Paediatrics, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy
    • ,
  • Chryssoula Tzialla

      Affiliations

    • Neonatology and Neonatal Intensive Care Unit, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy
    • ,
  • Iolanda Mazzucchelli

      Affiliations

    • Neonatal Immunology Laboratory, Neonatal Intensive Care Unit Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy
    • ,
  • Gianfranco Perotti

      Affiliations

    • Neonatology and Neonatal Intensive Care Unit, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy
    • ,
  • Carmine Tinelli

      Affiliations

    • Biometric Unit, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy
    • ,
  • Annalisa De Silvestri

      Affiliations

    • Biometric Unit, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy
    • ,
  • Paolo Manzoni

      Affiliations

    • Neonatology and Neonatal Intensive Care Unit, Sant'Anna Hospital, Azienda Ospedaliera Regina Margherita-Sant'Anna, C-Spezia 60, 10126 Torino, Italy
    • ,
  • Mauro Stronati

      Affiliations

    • Neonatology and Neonatal Intensive Care Unit, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy

Received 12 February 2010 ,Revised 31 March 2010 ,Accepted 16 April 2010.

References 

  1. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998;339:321–328
  2. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007;50:2357–2368
  3. Cantinotti M, Clerico A, Murzi M, Vittorini S, Emdin M. Clinical relevance of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in pediatric cardiology. Clin Chim Acta. 2008;390:12–22
  4. Koch A, Singer H. Normal values of B type natriuretic pepetide in infants, children and adolescents. Heart. 2003;89:875–878
  5. da Graca RL, Hassinger DC, Flynn PA, Sison CP, Nesin M, Auld PAM. Longitudinal changes of brain-type natriuretic peptide in preterm neonates. Pediatrics. 2006;117:2183–2189
  6. Das BB, Raj S, Solinger S. Natriuretic peptides in cardiovascular diseases of fetus, infants and children. Cardiovasc Hematol Agents Med Chem. 2009;7:43–51
  7. Choi BM, Lee KH, Eun BL, Yoo KH, Hong YS, Son CS, et al. Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants. Pediatrics. 2005;115:255–261
  8. CZernik C, Metze Lemmer J, Koehne PS B, Meuller C, Obladen M. B-Type natriuretic peptide to predict ductus intervention in infants<28weeks. Pediatric Res. 2008;64:286–290
  9. Flynn PA, da Graca RL, Auld PA, Nesin M, Kleinman CS. The use of a bedside assay for plasma B-type natriuretic peptide assay in the management of patent ductus arteriousus in premature neonates. J Pediatr. 2005;147:38–42
  10. Holmstrom H, Hall C, Thaulow E. Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriousus in preterm infants. Acta Paed. 2001;90:184–191
  11. Puddy VF, Amirmansour C, Williams AF, Singer DRJ. Plasma brain-type natriuretic peptide as predictor of haemodynamically significant patent ductus arteriosus in preterm infants. Clin Sci. 2002;103:75–77
  12. Sanjeev S, Pettersen M, Lua J, Thomas R, Shankaran S, L'Ecuyer T. Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates. J Perinatol. 2005;25:709–713
  13. Ko HK, Lee JH, Choi BM, Lee JH, Yoo KH, Son CS, et al. Utility of the rapid B-type natriuretic peptide assay for detection of cardiovascular problems in newborn infants with respiratory difficulties. Neonatology. 2008;94:16–21
  14. Reynolds EV, Ellington JG, Vranicar M, Bada HS. Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatrics. 2004;114:1297–1304
  15. Mannarino S, Ciardelli L, Garofoli F, Perotti G, Mongini E, Damiano S, et al. Correlation between cord blood, perinatal BNP values and echocardiographic parameters in healthy Italian newborns. Early Hum Dev. 2009;85:13–17
  16. El-Khuffash , Molloy EJ. Are B-type natriuretic peptide (BNP) and N-terminal-pro-BNP useful in neonates?. Arch Dis Child Fetal Neonatal Ed. 2007;92:F320–F324
  17. Deverux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Circulation. 1977;55:613–618

PII: S0378-3782(10)00084-8

doi: 10.1016/j.earlhumdev.2010.04.003

Early Human Development
Volume 86, Issue 5 , Pages 295-298 , May 2010

Article Tools

* Image Usage & Resolution